Member Info for Patagucci

At 2.0p as well.

Disappointing. But long term if this gets the money raised to get to where we need to be I guess suck it up and look to the future.

“Research continues on CBR and the Company intends to increase its focus on this once HEMO-CAR-T has entered clinical trials.“

CAR-T is technically clinical right, although not started trials. What’s people’s thoughts? Selling off this part of the company to fund others.

Either way what a week for RNSs, trust in the science and the SP will follow.

When will the market wake up to this?

He has deleted his account…

A clinical stage company, that seems very undervalued and now Vlad has gone off Twitter. Weird, so much to be proud of here yet it all feels a bit muted.

Let’s go

JHFH, if they receive it, is Hemo/Vlad allowed to not RNS it. And wait until it’s better timing. Isn't that withholding sensitive information?

I thought once he receives it, it will be then and there or 7AM next working day.

Apologies, it’s not AIM, I don’t know why I thought it was.

I know £80k is a big buy, but in the grand scheme of things is it? I don’t like putting out prediction but in 5 years I would love to know what this will be valued at.

Generally I find AIM is a loosing game. But occasionally you do get some gems. I’m hoping this is one of them.

Just gone through at 3.90.

I can see an UT, 100,000 shares at the same price. I didn’t by that many but I wonder if that’s the T212 account.

Don’t want to be out over weekend so just topped up on my trading212 account. Let’s see how long that takes to go through…

Still another small positive step.

Someone sold. In all seriousness no big sales went through when looking at the trades. Less than £70,000 was bought/sold. Small volume today really. A day closer to the RNS we are waiting for. Good or bad, this 6% won’t matter the day of the RNS.

Generally with investments it’s the case. But at this market cap I just don’t think I can. I’m not touching these shares. I’ve had bad luck with synairgen, still hold them. It was a risk I saw worth risking it for. I’m not selling either way. The potential is here with hemo, trust in the science and cross your fingers.

It’s already been said, but now a fair few have sold to try and make a quick profit on this, I hope a great RNS is released.

Can someone confirm exactly what the Universal trial is. From what I recall, isn’t it a J&J and synairgen collaboration observing patients who meet the criteria. No SNG001 administered etc.

i think there is a lot of ****ging off the bod, and sometimes i think rightly too. however, pharma isn’t simple. the goal is commercialisation. to achieve this we need successful trials. to get successful trials we need data and plans. there is little room for error. personally i hold faith, my biggest concern is will the company go bankrupt before we reach the end goal of commercialisation? it seems to me they are quietly making plans right now and have gathered a lot of data, the need for the drug hasn’t gone away.

Posted on X by synairgen

https://academic.oup.com/ofid/article/10/Supplement_2/ofad500.445/7448330

People belittling Hemo for still being sub 3p on a ‘great’ RNS… was it a great RNS? It’s a positive one which strengthens the company’s position. But a great RNS will be starting phase 1 trials, then 2, then 3 and then commercialisation. Let’s see if it’s 3p then!

Slow and steady and in the right direction

Another step in the right direction. Don’t expect it to change the SP much but good news.

I would say no to that, but in a year 3p will be a bargain.